biotech · Bile acid diarrhoea · Transthyretin cardiac amyloidosis · GLUE
Monte Rosa Therapeutics
Monte Rosa Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Boston, USA HQ
213 Employees
Public company Type
GLUE · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 213
- Programs
- 7
- Drugs
- 14
- Patents
- 72
Monte Rosa Therapeutics clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to Monte Rosa Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Monte Rosa Therapeutics trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Monte Rosa Therapeutics.
-
F106-CT01 — Phase 2
Clinical update -
Vyndaqel 61 mg soft capsules — Approved
Clinical update -
Temozolomide — Approved
Clinical update -
Oral MRT-2359 — Phase 2
Clinical update -
Cabergoline 1 MG — Phase 2
Clinical update -
MRT-6160 — Phase 1
Clinical update -
MRT-8102 — Phase 1
Clinical update -
Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
Patent grant